Exalenz Bioscience Ltd EXEN Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110

22:40 EST 3 Dec 2019 | BioPortfolio Reports

Exalenz Bioscience Ltd EXEN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Exalenz Bioscience Ltd Exalenz carries out the development and commercialization of advanced medical systems for a range of gastrointestinal GI tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional disorders. Its flagship product, BreathID Hp is a US FDA approved and European CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori H. pylori infection in adults as well as pediatric and tests patients of 3 to 17 years of age. It offers BreathID Gastro used for the diagnosis of liver and GI disorders. It also offers BreathID 13Cmethacetin breath test, a noninvasive point of care tool measures the microsomal function of the liver. Exalenz is headquartered in Modiin, Israel.

Exalenz Bioscience Ltd Key Recent Developments

Aug 31,2018: Exalenz Bioscience announces second quarter 2018 financial results

Apr 30,2018: Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer

Mar 12,2018: Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: Exalenz Bioscience Ltd EXEN Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110


More From BioPortfolio on "Exalenz Bioscience Ltd EXEN Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $110"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...